Iminoenamine based novel androgen receptor antagonist exhibited anti-prostate cancer activity in androgen independent prostate cancer cells through inhibition of AKT pathway
Keywords: Prostate cancer; T877A; Androgen receptor antagonist; Bicalutamide; LNCaP; Apoptosis; AR; Androgen receptor; DHT; Dihydrotestosterone; AIPC; Androgen Independent Prostate Cancer; LBD; Ligand Binding Domain; R-BIC; R-Bicalutamide; ETS; Erythroblast Transfo